Oral vinorelbine may not induce acute pain at the tumor site.
Tralongo
Paolo
P
Di Mari
Anna
A
Agueli
Roberta
R
Gebbia
Vittorio
V
D000284:Administration, Oral; D000972:Antineoplastic Agents, Phytogenic / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D009369:Neoplasms / Q000150:complications / Q000188:drug therapy*; D010146:Pain / Q000139:chemically induced* / Q000175:diagnosis*; D010147:Pain Measurement; D016896:Treatment Outcome; D014747:Vinblastine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D000077235:Vinorelbine
D000972:Antineoplastic Agents, Phytogenic; D014747:Vinblastine; D000077235:Vinorelbine